IT9020295A0 - Procedimento di dosaggio di anti-corpi igg anti-allergeni specifici, frazione ricca in ihg4 ottenuta secondo questo procedimento e composizione farmaceutica contenente questa frazione - Google Patents

Procedimento di dosaggio di anti-corpi igg anti-allergeni specifici, frazione ricca in ihg4 ottenuta secondo questo procedimento e composizione farmaceutica contenente questa frazione

Info

Publication number
IT9020295A0
IT9020295A0 IT9020295A IT2029590A IT9020295A0 IT 9020295 A0 IT9020295 A0 IT 9020295A0 IT 9020295 A IT9020295 A IT 9020295A IT 2029590 A IT2029590 A IT 2029590A IT 9020295 A0 IT9020295 A0 IT 9020295A0
Authority
IT
Italy
Prior art keywords
procedure
fraction
ihg4
allergens
dosing
Prior art date
Application number
IT9020295A
Other languages
English (en)
Other versions
IT9020295A1 (it
Inventor
Patrick Lambin
Clothilde Bremard-Oury
Original Assignee
Fond Nat Transfusion Sanguine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fond Nat Transfusion Sanguine filed Critical Fond Nat Transfusion Sanguine
Publication of IT9020295A0 publication Critical patent/IT9020295A0/it
Publication of IT9020295A1 publication Critical patent/IT9020295A1/it

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
IT020295A 1989-05-12 1990-05-14 Procedimento di dosaggio di anti-corpi igg anti-allergeni specifici, frazione ricca in ihg4 ottenuta secondo questo procedimento e composizione farmaceutica contenente questa frazione IT9020295A1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8906281A FR2646917A1 (fr) 1989-05-12 1989-05-12 Procede de dosage d'anti-corps igg anti-allergenes specifiques, fraction riche en igg4 obtenue selon ce procede et composition pharmaceutique contenant cette fraction

Publications (2)

Publication Number Publication Date
IT9020295A0 true IT9020295A0 (it) 1990-05-14
IT9020295A1 IT9020295A1 (it) 1991-11-14

Family

ID=9381627

Family Applications (1)

Application Number Title Priority Date Filing Date
IT020295A IT9020295A1 (it) 1989-05-12 1990-05-14 Procedimento di dosaggio di anti-corpi igg anti-allergeni specifici, frazione ricca in ihg4 ottenuta secondo questo procedimento e composizione farmaceutica contenente questa frazione

Country Status (3)

Country Link
FR (1) FR2646917A1 (it)
IT (1) IT9020295A1 (it)
WO (1) WO1990013817A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5367054A (en) * 1993-04-12 1994-11-22 Stolle Research & Development Corp. Large-scale purification of egg immunoglobulin
BRPI0800612A2 (pt) * 2008-01-02 2009-08-25 Fundacao Fapemig método e kit para a quantificação de subclasses de igg humanas especìficas a alérgenos para o acompanhamento da imunoterapia especìfica

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60228421A (ja) * 1984-04-27 1985-11-13 Shionogi & Co Ltd モノクロ−ナル抗ヒトＩｇＧ抗体およびその製造法
EP0161868B1 (en) * 1984-05-11 1992-11-04 BioWhittaker, Inc. Fluorometric assay of igg4
FR2578425B1 (fr) * 1985-03-07 1988-06-10 Nal Transfusion Sanguine Centr Preparations d'immunoglobulines presentant des titres eleves en anticorps bloquants anti-allergenes, leur preparation et leurs applications pour le traitement d'allergies
JPS61286754A (ja) * 1985-06-12 1986-12-17 Shionogi & Co Ltd モノクロ−ナル抗ヒトＩｇＧ↓４抗体およびその製造法

Also Published As

Publication number Publication date
FR2646917A1 (fr) 1990-11-16
WO1990013817A1 (fr) 1990-11-15
IT9020295A1 (it) 1991-11-14

Similar Documents

Publication Publication Date Title
IL105541A0 (en) Monoclonal antibodies to gp130 protein,processes for the preparation thereof and pharmaceutical compositions containing the same
IL78444A (en) Human gamma interferon-specific receptor protein,antibody against said protein,and compositions containing said protein and antibody
NZ236000A (en) Oligomeric monoclonal igg antibody composition
NZ228564A (en) Corticosteroid-containing skin care composition for use as moisturiser: preparation thereof
IT1162842B (it) Composizione farmaceutica topica per uso oftalmico e sua applicazione
EP0408859A3 (en) Monoclonal antibodies to activated endothelial cells
IL69198A (en) N-(bicyclic heterocyclyl)-4-piperidinamines,their preparation and pharmaceutical compositions containing them
FI924982A7 (fi) Pakastekuivattu preparaatti joka sisältää monokloonista vasta-ainetta
ZA908521B (en) Vaccine composition with non-immunosuppressive t cell epitope component
NZ221440A (en) Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
GB2186592B (en) Cross-protective human monoclonal antibody compositions
KR880700814A (ko) 아미노글리코사이드 스테로이드, 이의 제조방법, 이의 용도 및 이를 함유하는 약제학적 조성물
TR22765A (tr) Malzeme isitmaya mahsus oezellikle cam karma malzemesini sivilastirmaya mahsus cihaz
KR880700815A (ko) 아미노글리코사이드 스테로이드, 그의 제조방법, 그의 용도 및 이를 함유하는 약제학적 조성물
IT9020295A0 (it) Procedimento di dosaggio di anti-corpi igg anti-allergeni specifici, frazione ricca in ihg4 ottenuta secondo questo procedimento e composizione farmaceutica contenente questa frazione
DK138084A (da) Bundet lukkesammenstilling, fortrinsvis til pharmaceutiske beholdere
AU591579B2 (en) Antibodies for use in determining human glycoalbumin
EP0306680A3 (en) Monoclonal antibodies to anti-thrombin binding substance, and their uses
FI881596A7 (fi) Hammasteknisen koostumuksen säiliö sekä pakkaus.
FI894809A7 (fi) Farmaseuttinen koostumus keuhkotukosten hoitamiseksi
EP0205046A3 (en) Monoclonal antibody to human protein c
AU5217890A (en) Monoclonal antibodies in vaccine formulations
FI901958A7 (fi) Resiiniä estäviä dipeptidejä, menetelmä niiden valmistamiseksi, niitä sisältäviä aineita ja niiden käyttö
KR900019778U (ko) 스포이트가 부설된 화장품 용기
FR2608926B1 (fr) Antigene de babesia divergens, procede pour le produire et vaccin le contenant

Legal Events

Date Code Title Description
0002 Rejected